Actuate Therapeutics Inc
ACTU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $143,132 | $120,040 | $132,000 | $85,750 |
| - Cash | $16,925 | $6,493 | $3,889 | $8,642 |
| + Debt | $0 | $405 | $0 | $405 |
| Enterprise Value | $126,208 | $113,952 | $128,110 | $77,514 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,402 | -$5,944 | -$6,312 | -$6,323 |
| % Margin | – | – | – | – |
| Net Income | -$5,407 | -$5,949 | -$6,317 | -$6,446 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.25 | -0.3 | -0.32 | -0.6 |
| % Growth | 16.7% | 6.3% | 46.7% | – |
| Operating Cash Flow | -$6,678 | -$4,349 | -$4,619 | -$4,772 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$6,678 | -$4,349 | -$4,619 | -$4,772 |